BY CHRISTOPHER DUE KARLSSON
-
GN Hearing exec on retail divestment: Hard to expand crucial partnerships as a rival
The sale of the retail chain Dansk Hørecenter to rival Demant is a pure step within the completion of GN’s technique, says Scott Davis, head of GN’s Listening to division.
-
Zealand Pharma has almost doubled staff roster: “We will continue to hire”
According to president Adam Steensberg, the biotech business’s labor force, which at one factor was to 180 individuals, is currently coming close to 300 staff members.
-
Best PC computer deals: Top picks from desktops to all-in-ones
Whether you’re trying to find an efficiency desktop computer, a pc gaming computer giant, or a fashionable all-in-one Windows maker, we have actually obtained you covered. Th…
-
Zealand Pharma raises cost outlook amid push for weight loss drug development
CEO Adam Steensberg explains that this summer season’s optimistic trial information and capital injection has made Zealand Pharma transfer sooner with higher breadth and depth.
-
Demant CEO on cost-cutting measures: Provides some good and clear savings
Søren Nielsen, CEO of the listening to assist firm, explains that the measures embody re-filling positions and financial savings in relation to air journey.
-
Novo Nordisk starts Phase II trial with amycretin in T2D and obesity
The research study is anticipated to be finished in loss 2025.
